Dr. Rachid Karam is passionate about bridging cutting-edge technologies to improve patient outcomes, making him an ideal fit for his role as Vice President of Research & Development at Ambry Genetics. In this position, Dr. Karam has spearheaded initiatives to improve the diagnostic yield of DNA tests, including integrating RNA sequencing into clinical genetic testing. He earned his M.D. in Brazil, a Ph.D. in Oncogenetics from the University of Porto, Portugal, and completed a postdoctoral fellowship at the University of California, San Diego.